Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report

Effective treatment or prevention of immune side effects associated with checkpoint inhibitor therapy of cancer is an important goal in this new era of immunotherapy. Hepatitis due to immunotherapy with antibodies against PD-1 is uncommon and generally of low severity. We present an unusually severe...

Descripción completa

Detalles Bibliográficos
Autores principales: McGuire, Helen M., Shklovskaya, Elena, Edwards, Jarem, Trevillian, Paul R., McCaughan, Geoffrey W., Bertolino, Patrick, McKenzie, Catriona, Gourlay, Ralph, Gallagher, Stuart J., Fazekas de St. Groth, Barbara, Hersey, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860100/
https://www.ncbi.nlm.nih.gov/pubmed/29289977
http://dx.doi.org/10.1007/s00262-017-2107-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860100/
https://www.ncbi.nlm.nih.gov/pubmed/29289977
http://dx.doi.org/10.1007/s00262-017-2107-7

Ejemplares similares